Narrative review / 2014
Intestinal microbiota and fecal transplantation are implicated in regulating human glucose and lipid metabolism in insulin resistance and type 2 diabetes.
This review examines the role of intestinal microbiota and fecal transplantation in insulin resistance and type 2 diabetes mellitus. Alterations in intestinal microbiota composition promote systemic inflammation, which is a hallmark of obesity and subsequent insulin resistance. Fecal transplantation studies indicate that butyrate-producing intestinal bacteria are crucial key players in regulating diverse signaling cascades linked to human glucose and lipid metabolism.
- Study type
- Narrative review
- Who was studied
- Individuals with insulin resistance, obesity, and type 2 diabetes
- What was measured
- Glucose and lipid metabolism, systemic inflammation, insulin resistance
THE PAPER
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.
Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M. Clin Exp Immunol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.